Evotec SE (EVO) Equity Income (2020 - 2022)
Evotec SE (EVO) posted Equity Income of -$16.3 million for Q4 2022, down 447004.64% sequentially from $3641.9 in Q3 2022, and up 14.21% YoY from -$14.3 million in Q4 2021.
Evotec SE (EVO) Equity Income (2020 - 2022) Analysis & Trends
Evotec SE has reported Equity Income for 3 years, with the latest figure at -$16.3 million in Q4 2022.
- Quarterly Equity Income rose 14.21% year-over-year to -$16.3 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was -$16.3 million (up 14.22% YoY) and the FY2022 annual result came in at -$16.3 million, up 14.08% from the prior year.
- Equity Income eased to -$16.3 million in Q4 2022 per EVO's latest filing, from $3641.9 in the prior quarter.
- Over five years, Equity Income peaked at $5407.0 in Q3 2020 and troughed at -$19.0 million in Q4 2021.
- A 3-year average of -$4.8 million and a median of -$4650.9 in 2021 frame the typical range for Equity Income.
- The sharpest annual moves came in 2021 and 2022: Equity Income plunged 52.38% in 2021, then soared 35.51% in 2022.
- Over 3 years, Equity Income stood at -$12.5 million in 2020, then plunged by 52.38% to -$19.0 million in 2021, then gained by 14.21% to -$16.3 million in 2022.
- According to Business Quant data, Equity Income over the past three periods registered -$16.3 million, $3641.9, and -$3764.6 for Q4 2022, Q3 2022, and Q2 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -500,000.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 3.38 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Evotec SE | 692.56 Mn | 692.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -16.28 Mn |
| Sep 30, 2022 | 3,641.89 |
| Jun 30, 2022 | -3,764.58 |
| Mar 31, 2022 | -4,601.58 |
| Dec 31, 2021 | -18.97 Mn |
| Sep 30, 2021 | 4,560.30 |
| Jun 30, 2021 | -4,700.27 |
| Mar 31, 2021 | -7,134.89 |
| Dec 31, 2020 | -12.45 Mn |
| Sep 30, 2020 | 5,407.03 |